MDV
Q4 2026 EPS Estimate
$0.02
Nov 13, 2026
Revenue Estimate
$12M
FY2026E EPS$0.07
FY2027E EPS$0.12

Analyst Sentiment

Wall St. Consensus
Buy
8 analysts·Limited coverage
72
Score
7 Buy (88%)1 Hold (13%)0 Sell (-1%)
Rating Breakdown
Strong Buy
00%
Buy
788%
Hold
113%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$19.00
+5.3%
Consensus
$19.00
+5.3%
Bull
$19.00
+5.3%
12-Month Target Range8 analysts
$19.00$19.00$19.00
Current $18.05Consensus
Current Price
$18.05
Upside to Consensus
$0.95

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+4.44%
EPS+71.43%
FY2028
Rev-0.98%
EPS+300.00%
FY2029
Rev-0.97%
EPS+6.25%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
MetricFY2026EFY2027EFY2028EFY2029EFY2030E
Revenue Avg$46M$48M$48M$47M$49M
Low$44M$45M$46M$45M$46M
High$48M$51M$49M$49M$50M
EBITDA Avg$29M$30M$30M$30M$31M
Low$28M$28M$29M$28M$29M
High$30M$32M$31M$31M$32M
EBIT Avg$32M$33M$33M$32M$33M
Low$30M$31M$31M$31M$32M
High$33M$35M$34M$33M$34M
Net Income Avg$810,322$1M$6M$6M
Low$768,084$1M$5M$6M
High$852,560$1M$6M$6M
EPS Avg$0.07$0.12$0.48$0.51
Low$0.07$0.11$0.45$0.48
High$0.07$0.13$0.50$0.53
Analysts (Rev / EPS)4 / 16 / 12 / 11 / 11 /
Quarterly
MetricQ3 2026Q4 2026Q1 2027Q2 2027Q3 2027Q4 2027
Revenue Avg$12M$12M$12M$12M$13M$13M
Low$11M$11M$11M$12M$12M$12M
High$12M$12M$12M$13M$13M$13M
EBITDA Avg$7M$7M$8M$8M$8M$8M
Low$7M$7M$7M$7M$7M$8M
High$7M$7M$8M$8M$8M$8M
EBIT Avg$8M$8M$8M$8M$9M$9M
Low$7M$8M$8M$8M$8M$8M
High$8M$8M$8M$9M$9M$9M
Net Income Avg$256,240$384,361$-128,120$640,602$512,481$512,481
Low$237,699$356,549$-130,823$594,248$475,398$475,398
High$261,646$392,470$-118,849$654,116$523,293$523,293
EPS Avg$0.02$0.03$-0.01$0.05$0.04$0.04
Low$0.02$0.03$-0.01$0.05$0.04$0.04
High$0.02$0.03$-0.01$0.05$0.04$0.04
Analysts (Rev / EPS)6 / 13 / 13 / 13 / 13 / 13 / 1

Earnings Surprises

Recent Analyst Actions

May 4, 2026Cantor Fitzgerald
Modiv downgraded to Neutral from Overweight at Cantor Fitzgerald
Target:$19.00
+6.2%from $17.89
Feb 3, 2026Cantor Fitzgerald
Modiv initiated with an Overweight at Cantor Fitzgerald
Target:$18.00
+18.4%from $15.20
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.